Skip to content
Change the repository type filter

All

    Repositories list

    • An example study using Strategus >= 1.0
      R
      0000Updated Nov 28, 2024Nov 28, 2024
    • Glp1Dili

      Public
      R
      Apache License 2.0
      3010Updated Nov 26, 2024Nov 26, 2024
    • Validating the COVID prediction models across time and databases
      R
      0100Updated Nov 19, 2024Nov 19, 2024
    • Establish and evaluate a comprehensive set of objective diagnostics for the Self-Controlled Case Series(SCCS) design
      R
      0000Updated Nov 18, 2024Nov 18, 2024
    • Strategus study repository template
      R
      Apache License 2.0
      2310Updated Nov 15, 2024Nov 15, 2024
    • R
      161051Updated Nov 11, 2024Nov 11, 2024
    • [under development]
      0000Updated Nov 7, 2024Nov 7, 2024
    • Development of prediction models to predict short term mortality after interventions for tetraplegic patients
      R
      1010Updated Oct 24, 2024Oct 24, 2024
    • A demonstration of the HADES open source tools
      HTML
      0000Updated Oct 18, 2024Oct 18, 2024
    • OHDSI Network Study lead by John Hopkins Myositis Group
      R
      Apache License 2.0
      0200Updated Oct 15, 2024Oct 15, 2024
    • OHDSI network study for population-level effect estimation of risk of NAION and other vision disorders from exposure to semaglutide.
      R
      4321Updated Oct 15, 2024Oct 15, 2024
    • Methods research investigating a way to estimate external validation using summary statistics
      R
      0100Updated Oct 15, 2024Oct 15, 2024
    • CHAPTER

      Public
      Characterization of Health by OHDSI Asia-Pacific chapter to identify Temporal Effect of the Pandemic
      R
      1031Updated Sep 20, 2024Sep 20, 2024
    • LEGEND-T2DM Evidence Explorer
      R
      3100Updated Sep 19, 2024Sep 19, 2024
    • Investigating different deep learning approaches
      R
      3500Updated Sep 6, 2024Sep 6, 2024
    • Troy

      Public
      R
      2000Updated Aug 30, 2024Aug 30, 2024
    • R
      1120Updated Aug 13, 2024Aug 13, 2024
    • Characterization study of inflammatory bowel disease
      R
      Apache License 2.0
      2120Updated Jul 23, 2024Jul 23, 2024
    • R
      1100Updated Jul 19, 2024Jul 19, 2024
    • SAGE

      Public
      R
      Apache License 2.0
      1000Updated Jul 9, 2024Jul 9, 2024
    • This comprehensive study aims to understand STEMI patients’ characteristics and identify the incidence rates across multiple real-world data datasets.
      R
      1000Updated Jul 2, 2024Jul 2, 2024
    • Empirically evaluates QBA for outcome phenotype error correction in several pharmacoepidemiologic comparative effect estimation scenarios. Simulates an analytic space defined by outcome incidence proportions, observed effect estimates, and phenotype measurement errors to determine which QBA input combinations produce valid results.
      HTML
      0000Updated Jun 19, 2024Jun 19, 2024
    • [under development]
      R
      9130Updated Jun 19, 2024Jun 19, 2024
    • In this study,we evaluate the changes in osteoporosis medication treatment patterns in postmenopausal women.
      R
      1000Updated Jun 18, 2024Jun 18, 2024
    • This research developed and evaluated an algorithm to link mothers and infants in two US administrative databases to facilitate research on prenatal medication exposure and infant health outcomes.
      R
      Apache License 2.0
      1000Updated Jun 17, 2024Jun 17, 2024
    • glp1HIRA

      Public
      R
      0100Updated May 15, 2024May 15, 2024
    • TeX
      2001Updated May 13, 2024May 13, 2024
    • DdiPpiClo

      Public
      A study package to investigate drug-drug interaction between Proton pump inhibitor and Clopidogrel
      R
      2010Updated Apr 12, 2024Apr 12, 2024
    • HowOften

      Public
      [under development] Large-scale incidence characterization
      HTML
      9621Updated Apr 11, 2024Apr 11, 2024
    • Eumaeus

      Public
      Evaluating Use of Methods for Adverse Event Under Surveillance (for vaccines)
      HTML
      3200Updated Apr 2, 2024Apr 2, 2024